Zantac Intestinal Cancer

 Zantac and other ranitidine medications have been determined to contain the dangerous contaminant NDMA (N-Nitrosodimethylamine), which is widely deemed a probable carcinogen (cancer-causing agent). Further, the instability of the ranitidine molecule in these medications may contribute to the production of increased levels of NDMA in the body. One of the cancers associated with elevated levels of NDMA is intestinal cancer.

The Symptoms of Intestinal Cancer

According to the Cancer Treatment Centers of America, intestinal cancer involves tumors in the small intestine that can block and otherwise hinder the digestion process. As a tumor grows, pain can result. Common symptoms associated with intestinal cancer include:

• Unintentional weight loss
• Pain in the abdomen
• Bloody or tarry stools (the result of bleeding tumors)
• Fatigue and/or weakness (which is sometimes caused by a slowly bleeding tumor that leads to anemia)
• A noticeable protrusion in the abdomen

Because the associated symptoms can be quite vague, Intestinal cancer is often difficult to diagnose, which also makes obtaining the necessary treatment more precarious. If you’ve been a regular Zantac user and develop any of the symptoms listed – or have any other related health concerns – it’s in your best interest to seek medical attention.

Don’t Delay Consulting with an Experienced Drug Injury Attorney

If you took Zantac regularly and have been diagnosed with intestinal cancer, a dedicated drug injury attorney has the fortitude and resources to skillfully advocate for the compensation to which you are entitled and that you need to reach your most complete recovery.